Publication | Closed Access

CXCL5, the upregulated chemokine in patients with uterine cervix cancer, in vivo and in vitro contributes to oncogenic potential of Hela uterine cervix cancer cells

Cervical CancerMalignant DiseaseMedicineUpregulated ChemokineGynecologyOncogenic PotentialUterine Cervix CancerCancer BiologyOncologyCell BiologyTumor MicroenvironmentTumor Biology